Evaluation of serum electrolytes (sodium na+, potassium k, chloride cl, and bicarbonate hco-3) and c-reactive protein in preeclampsia patients

Thesis Abstract

Abstract
Preeclampsia is a serious complication of pregnancy characterized by high blood pressure and often the presence of protein in the urine. It can lead to severe complications for both the mother and the baby if not managed promptly. Electrolyte imbalances have been implicated in the pathophysiology of preeclampsia, with sodium, potassium, chloride, and bicarbonate playing crucial roles in maintaining normal physiological functions. Additionally, inflammation has been suggested to play a role in the development and progression of preeclampsia, with C-reactive protein (CRP) being a marker of systemic inflammation. This study aimed to evaluate the levels of serum electrolytes (sodium, potassium, chloride, and bicarbonate) and C-reactive protein in preeclampsia patients compared to normotensive pregnant women. A total of 100 participants were recruited, including 50 preeclampsia patients and 50 normotensive pregnant women as controls. Serum samples were collected and analyzed for sodium, potassium, chloride, bicarbonate, and CRP levels using standard laboratory methods. The results showed that preeclampsia patients had significantly higher levels of sodium and chloride compared to normotensive pregnant women (p < 0.05). In contrast, potassium levels were significantly lower in preeclampsia patients compared to controls (p < 0.05). Bicarbonate levels were also lower in preeclampsia patients, but the difference was not statistically significant (p > 0.05). Furthermore, CRP levels were significantly elevated in preeclampsia patients compared to controls (p < 0.05), indicating the presence of systemic inflammation in these patients. The findings of this study suggest that alterations in serum electrolyte levels, particularly sodium, potassium, and chloride, may play a role in the pathophysiology of preeclampsia. The elevated CRP levels further support the involvement of inflammatory processes in the development of this condition. Monitoring these biomarkers in preeclampsia patients could potentially aid in the early detection and management of the disease, leading to improved outcomes for both the mother and the baby. Further research is warranted to elucidate the mechanisms underlying these electrolyte imbalances and inflammatory responses in preeclampsia, paving the way for targeted therapeutic interventions.